Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
New Covid boosters approved as CDC set to decide who should receive them amid rising cases Monday 11 September 2023 19:38 , Graeme Massie Health officials say that the Pfizer and Moderna shots ...
On Monday, the U.S. Food and Drug Administration approved new mRNA boosters from Moderna and Pfizer. Approval for another booster from Novavax is likely forthcoming. Approval for another booster ...
Last year's fall booster was approved in mid-September 2023 and protected against XBB coronavirus strains, for example. But experts are predicting yet another wave to occur later in the year, as ...
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
The FDA authorizes the first bivalent COVID-19 booster for ages 5-11. ... CDC approves Pfizer, Moderna's COVID-19 boosters for ages 5 and up. Anjalee Khemlani. October 12, 2022 at 10:24 AM.
mRNA-1283 is a COVID-19 vaccine candidate developed by Moderna. [ 2 ] [ 3 ] Compared to prior mRNA vaccines, this candidate has a storage temperature of 2-5 °C, compatible with vaccine storage in a standard refrigerator, rather than low temperature freezers. [ 4 ]
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...